Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 8, 2003, Pages 2538-2544

  Silverman, Jared A ^a   Perlmutter, Nancy G ^b   Shapiro, Howard M ^b  

^a CUBIST PHARMACEUTICALS INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CALCIUM; DAPTOMYCIN; LIPOPEPTIDE; POTASSIUM; VALINOMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; CELL MEMBRANE; CELL VIABILITY; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DRUG MECHANISM; FLOW CYTOMETRY; FLUORESCENCE; FLUOROMETRY; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; CULTURE MEDIA; DAPTOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FLUOROMETRY; MEMBRANE POTENTIALS; POTASSIUM; STAPHYLOCOCCUS AUREUS;

EID: 0041592783     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.8.2538-2544.2003     Document Type: Article

References (28)

1. Alborn, W. E., Jr., N. E. Allen, and D. A. Preston. 1991. Daptomycin disrupts membrane potential in growing Staphylococcus aureus. Antimicrob. Agents Chemother. 35:2282-2287.
2. Allen, N. E., W. E. Alborn, Jr., and J. N. Hobbs, Jr. 1991. Inhibition of membrane potential-dependent amino acid transport by daptomycin. Antimicrob. Agents Chemother. 35:2639-2642.
3. Andrew, J. H., M. C. Wale, L. J. Wale, and D. Greenwood. 1987. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. J. Antimicrob. Chemother. 20:213-221.
4. Barry, A. L., P. C. Fuchs, and S. D. Brown. 2001. In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob. Agents Chemother. 45:1919-1922.
5. Boaretti, M., and P. Canepari. 1995. Identification of daptomycin-binding proteins in the membrane of Enterococcus hirae. Antimicrob. Agents Chemother. 39:2068-2072.
6. Boaretti, M., and P. Canepari. 2000. Purification of daptomycin binding proteins (DBPs) from the membrane of Enterococcus hirae. New Microbiol. 23:305-317.
7. Boaretti, M., P. Canepari, M. D. M. Lleo, and G. Satta. 1993. The activity of daptomycin on Enterococcus faecium protoplasts: indirect evidence supporting a novel mode of action on lipoteichoic acid synthesis. J. Antimicrob. Chemother. 31:227-235.
8. Canepari, P., M. Boaretti, M. del Mar Lleo, and G. Satta. 1990. Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032). Antimicrob. Agents Chemother. 34:1220-1226.
9. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.
10. Fuchs, P. C., A. L. Barry, and S. D. Brown. 2002. In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 49:467-470.
11. Herranz, C., L. M. Cintas, P. E. Hernandez, G. N. Moll, and A. J. Driessen. 2001. Enterocin P causes potassium ion efflux from Enterococcus faecium T136 cells. Antimicrob. Agents Chemother. 45:901-904.
12. King, A., and I. Phillips. 2001. The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates. J. Antimicrob. Chemother. 48:219-223.
13. Laganas, V., J. Alder, and J. A. Silverman. 2003. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inbibition of lipoteichoic acid biosynthesis. Antimicrob. Agents Chemother. 47:2682-2684.
14. Lakey, J. H., and M. Ptak. 1988. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry 27:4639-4645.
15. Lamp, K. C., M. J. Rybak, E. M. Bailey, and G. W. Kaatz. 1992. In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin. Antimicrob. Agents Chemother. 36:2709-2714.
16. Maget-Dana, R., and F. Peypoux. 1994. Iturins, a special class of poreforming lipopeptides: biological and physicochemical properties. Toxicology 87:151-174.
17. National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.
18. Novo, D., N. G. Perlmutter, R. H. Hunt, and H. M. Shapiro. 1999. Accurate flow cytometric membrane potential measurement in bacteria using diethyloxacarbocyanine and a ratiometric technique. Cytometry 35:55-63.
19. Ruhr, E., and H. G. Sahl. 1985. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27:841-845.
20. Rybak, M. J., E. Hershberger, T. Moldovan, and R. G. Grucz. 2000. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 44:1062-1066.
21. Sahl, H. G., M. Kordel, and R. Benz. 1987. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch. Microbiol. 149:120-124.
22. Silverman, J. A., N. Oliver, T. Andrew, and T. Li. 2001. Resistance studies with daptomycin. Antimicrob. Agents Chemother. 45:1799-1802.
23. Snydman, D. R., N. V. Jacobus, L. A. McDermott, J. R. Lonks, and J. M. Boyce. 2000. Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob. Agents Chemother. 44:3447-3450.
24. Wise, R., J. M. Andrews, and J. P. Ashby. 2001. Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint. J. Antimicrob. Chemother. 48:563-567.
25. Wu, M., and R. E. Hancock. 1999. Interaction of the cyclic antimicrobial cationic peptide bactenecin with the outer and cytoplasmic membrane. J. Biol. Chem. 274:29-35.
26. Wu, M., E. Maier, R. Benz, and R. E. Hancock. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. 38:7235-7242.
27. Xiong, Y. Q., M. R. Yeaman, and A. S. Bayer. 1999. In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob. Agents Chemother. 43:1111-1117.
28. Yeaman, M. R., A. S. Bayer, S. P. Koo, W. Foss, and P. M. Sullam. 1998. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J. Clin. Investig. 101:178-187.